Home > Healthcare > Medical Devices > Women Health Devices Market

Women Health Devices Market Analysis

  • Report ID: GMI3191
  • Published Date: Aug 2024
  • Report Format: PDF

Women Health Devices Market Analysis

Based on product, the market is divided into devices and consumables. The devices segment is further bifurcated into contraceptive devices, fertility monitoring devices, menstrual health products, breast health devices, pelvic health devices, maternal health products, general health monitoring devices, medical devices for gynecological conditions, and other devices. The devices segment of the market is forecasted to reach USD 211.4 billion by 2032.
 

  • This growth is fueled by a convergence of factors, including increasing awareness among women about their health needs and the availability of specialized devices.
     
  • Technological advancements have led to the development of more efficient and user-friendly products, catering to various aspects of women's health. A shift towards preventive healthcare, coupled with changing lifestyles and demographics, has spurred demand for devices such as fertility monitors, menstrual health products, breast health devices, and general health monitoring devices.
     
  • Moreover, an expanding range of product offerings, favorable regulatory policies, increased investments in women's health research and development, and rising healthcare expenditures have all contributed to the robust growth of the women's health devices segment.
     

Women Health Devices Market, By Application (2023)

Based on application, the women health devices market is bifurcated into cancer, osteoporosis, infectious diseases, uterine fibroids, pregnancy, female sterilization, menstrual disorders, and other applications. Infectious diseases segment is anticipated to witness significant growth over the analysis timeframe, at a CAGR of 7.9%.
 

  • Infectious diseases, particularly those impacting women's health such as urinary tract infections (UTIs), sexually transmitted infections (STIs), and vaginal infections, remain prevalent globally. For instance, in 2022, the World Health Organization (WHO) documented that twenty million women were HIV-positive, with 540,000 newly acquiring the virus, and 23,000 succumbing to HIV-related complications.
     
  • Additionally, vaginal candidiasis, as highlighted by the CDC, is widespread, ranking as the second most common type of vaginal infection in the U.S., following bacterial vaginal infections. An estimated 1.4 million outpatient visits are associated with vaginal candidiasis annually.
     
  • Therefore, the rising incidence of these diseases underscores the necessity for the development and adoption of specialized devices for their diagnosis, monitoring, and treatment, thereby driving market growth.
     

Based on end-user, women health devices market is bifurcated into hospitals, obstetrics & gynecology clinics, diagnostic laboratories, ambulatory surgical centers, and other end-users. The diagnostic laboratories segment accounted for USD 44.5 billion in 2023.
 

  • Diagnostic laboratories play a crucial role in accurately and promptly assessing various health conditions, particularly those specific to women, such as breast cancer, cervical cancer, osteoporosis, and reproductive health issues.
     
  • Technological advancements, including innovations in imaging techniques, molecular diagnostics, and automation, have significantly improved the accuracy, efficiency, and accessibility of diagnostic tests within these laboratories.
     
  • Moreover, collaboration between diagnostic laboratories, healthcare providers, and medical device manufacturers further fosters innovation, leading to the development and adoption of advanced diagnostic technologies tailored to women's health needs.
     

North America Women Health Devices Market, 2021 – 2032 (USD Billion)

The growth of the women health devices market in the U.S. is projected to reach USD 78.8 billion by 2032.
 

  • Growing awareness about women’s health issues and the importance of preventive care is propelling the demand for specialized health devices. Efforts to promote regular screenings and early diagnosis, particularly for conditions such as breast cancer and osteoporosis, are boosting market growth in the country.
     
  • Other factors driving the growth of the U.S. women’s health devices market include increasing healthcare expenditure, favorable government initiatives, advancements in medical technology, and the rising prevalence of lifestyle-related diseases. These elements collectively enhance the accessibility and quality of women’s healthcare, further expanding the market.
     

The women health devices market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

  • Continuous advancements in technology are leading to the development of more sophisticated women’s health devices. Innovations such as wearable health monitors, smart breast pumps, and advanced diagnostic tools are making it easier for women to manage their health.
  • Further, the integration of health devices with digital platforms, such as mobile apps and telemedicine, is enhancing their functionality and accessibility, contributing to market growth in the country.

Japan women health devices market is anticipated to witness lucrative growth between 2024 – 2032.
 

  • Japan has one of the world's oldest populations, with a growing proportion of elderly women. This demographic shift is increasing the demand for health devices that address age-related health issues, including osteoporosis, cardiovascular diseases, and menopause management.
     

The women health devices market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

  • The Saudi government's healthcare initiatives, including the Vision 2030 program, are focused on improving healthcare infrastructure and accessibility. By investing in healthcare facilities and technology, these initiatives foster the adoption of innovative women's health devices, such as those for gynecological health, pregnancy monitoring, and menopause management. This investment is driving significant growth in the women's health devices market in the region.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The women health devices market size was valued at USD 129.9 billion in 2023 and is estimated to grow at 9.2% CAGR from 2024 to 2032 driven by the increasing disease burden among women in developed countries.

The devices segment in the market is expected to reach USD 211.4 billion by 2032 fueled by increasing awareness among women about their health needs and the availability of specialized devices.

U.S. women health devices market is projected to reach USD 78.8 billion by 2032 owing to the growing awareness about women health issues.

Abbott Laboratories, Allengers Medical, Alphabet Inc., Caldera Medical, Carestream Health, Garmin Ltd., GE Healthcare Technologies Inc., Hologic, Inc., Koninklijke Philips N.V., Mankind Pharma Limited, OMRON Corporation, and aOrganon & Co.

Women Health Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 328
  • Countries covered: 26
  • Pages: 199
 Download Free Sample